Oregovomab Plus Chemo in Newly Diagnosed Patients with Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery (FLORA-5/GOG-3035)Stephanie N. Gregory, Sunil Gupta, Amber Leila Sarvestani et al.|Annals of Surgical Oncology|2022Cited by 22
Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocolJack H. Victory, Jonathan M. Hernandez, Bhavishya Ramamoorthy et al.|Journal of Gastrointestinal Oncology|2024Cited by 9
A Randomized Study of Olaparib or Placebo in Patients with Surgically Removed Pancreatic Cancer who have a BRCA1, BRCA2 or PALB2 Mutation (The APOLLO Trial)Martha E. Teke, Kim A. Reiss, Areeba Saif et al.|Annals of Surgical Oncology|2022Cited by 6
Neoadjuvant Chemotherapy Plus Living Donor Transplantation (LDLT) for Non-Resectable Liver Metastases from Colorectal Cancer (CRC)Jacob Lambdin, David Al‐Adra, Carrie E. Ryan et al.|Annals of Surgical Oncology|2022Cited by 5
Durvalumab and Tremelimumab for Hepatocellular Carcinoma in Patients Listed for a Liver TransplantCarrie E. Ryan, Davendra Sohal, Jacob T. Lambdin et al.|Annals of Surgical Oncology|2022Cited by 3